Cofrogliptin
Cofrogliptin (HSK7653) is an oral DPP-4 inhibitor developed for type 2 diabetes research. It exhibits hypoglycemic activity by inhibiting the degradation of incretin hormones, making it suitable for in vitro enzymatic assays and in vivo metabolic studies in diabetic animal models.
Product Specifications
CAS Number
1844874-26-5
Field of Research
Protein Biochemistry
Purity
99.25% (May vary between batches)
Smiles
C (F) (F) (F) [C@@H]1[C@@H] (C[C@H] (N) [C@H] (O1) C2=C (F) C=CC (F) =C2) N3CC=4C (C3) =NN (S (C) (=O) =O) C4
Molecular Formula
C18H19F5N4O3S
Molecular Weight
466.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
364147 200 µL
MIF (Macrophage Migration Inhibitory Factor, GIF, GLIF, MMIF, Glycosylation-Inhibiting Factor, L-dopachrome isomerase, L-dopachrome tautomerase, Phenylpyruvate tautomerase)
Sign In for Pricing
View Details 
IRBAHUIFNA1AAP067200UL 1 Each
Rabbit Anti Human IFNA1; Polyclonal Antigen affinity Purified (PBS with 0.05% NaN3 and 40% Glycerol, pH7.4) (IHC,ELISA)
Sign In for Pricing
View Details OR1086544-01 250 mg
Ethyl 2- (3-methoxy-4- (methylthio) phenyl) -2-oxoacetate
Sign In for Pricing
View Details